Role of Cyclooxygenase-2 on development and progression of colorectal cancer and its chemopreventive effect.
Cyclooxygenase-2 在结直肠癌发生和进展中的作用及其化学预防作用。
基本信息
- 批准号:14570494
- 负责人:
- 金额:$ 1.34万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2002
- 资助国家:日本
- 起止时间:2002 至 2004
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Although accumulated knowledge has shown that cyclooxygenase-2(COX-2) plays an important role in the occurrence and the progression of colorectal tumor, the mechanism how COX-2 promotes colorectal tumorigenesis remains unclear. One intriguing finding is that the expression of COX-2 impairs the apoptotic response. In this study we investigated when COX-2 protein starts to overexpress in colorectal tumors in the process of developing cancer from adenoma and whether COX-2 expression correlates with proliferation and/or apoptosis in human sporadic colorectal cancers. MATERIALS & METHODS : A retrospective review of patients with early colorectal tumor was performed. Immunohistochemical analysis was performed on paraffin-embedded tissue samples using a COX-2 antibody. Proliferation and apoptosis were investigated on serial sections by Ki-67 antibody and TUNEL method as well as p53 immunohistochemistry. COX-2 score, Ki-67 labeling index, apoptotic index and p53-positive ratio were calculated … More at both surface and deeper parts of the tumor. The relationship between Ki-67 labeling index or apoptotic index, p53-positive ratio and COX-2 score at each part of the tumor was analyzed. RESULTS : In colorectal tumors, marked expression of immunoreactive COX-2 was present not only in interstitial cells including inflammatory mononuclear cells, vascular endothelial cells and fibroblasts, but also in tumor cells. In proportion as the tumor increased in size, COX-2 positive ratio increased. The COX-2 score and p53 positive ratio at deeper part of cancers were higher than those at surface part. Ki-67 labeling index at deeper part was significantly lower than that at surface part. At surface part the COX-2 score of p53-positive cancers was higher than that of p53-negative cancers. The apoptotic index showed no correlation with COX-2 score. At deeper part, on the other hand, lower apoptotic index correlated with higher COX-2 score. The Ki-67 labeling index and p53 positive ratio showed no correlation with COX-2 score. The apoptotic index of p53-positive cancers was significantly lower than that of p53-negative cancers at both surface and deeper parts. CONCLUSIONS : These evidences support the hypothesis that COX-2 promotes development of colorectal tumors, one of which mechanisms is to prevent apoptosis with p53-independent pathway. Less
尽管越来越多的研究表明环氧合酶-2(cyclooxygenase-2,考克斯-2)在结直肠肿瘤的发生、发展中起重要作用,但考克斯-2促进结直肠肿瘤发生的机制尚不清楚。一个有趣的发现是考克斯-2的表达削弱了凋亡反应。在本研究中,我们调查了考克斯-2蛋白在结直肠肿瘤中何时开始过表达,以及考克斯-2表达是否与人散发性结直肠癌的增殖和/或凋亡相关。材料与方法:对早期结直肠肿瘤患者进行回顾性分析。使用考克斯-2抗体对石蜡包埋的组织样品进行免疫组织化学分析。连续切片采用Ki-67抗体、TUNEL法及p53免疫组化法检测细胞增殖和凋亡。计算考克斯-2评分、Ki-67标记指数、凋亡指数和p53阳性率 ...更多信息 在肿瘤的表面和更深的部分。分析肿瘤各部位Ki-67标记指数或凋亡指数、p53阳性率与考克斯-2评分的关系。研究结果:在结直肠肿瘤中,免疫反应性考克斯-2的显著表达不仅存在于间质细胞,包括炎性单核细胞、血管内皮细胞和成纤维细胞,而且存在于肿瘤细胞中。考克斯-2阳性率随肿瘤体积增大而增加。癌组织深部考克斯-2评分和p53阳性率均高于癌组织表面。Ki-67标记指数在深部明显低于表层。p53阳性组的考克斯-2评分高于p53阴性组。凋亡指数与考克斯-2评分无相关性。在更深的部分,另一方面,较低的凋亡指数与较高的考克斯-2评分相关。Ki-67标记指数和p53阳性率与考克斯-2评分无相关性。p53阳性组的细胞凋亡指数在浅表和深部均显著低于p53阴性组。结论:这些证据支持了考克斯-2促进结直肠肿瘤发生发展的假说,其机制之一是通过p53非依赖性途径阻止细胞凋亡。少
项目成果
期刊论文数量(22)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
S.Imamura: "Vector potential of cockroaches for Helicobacter pylori infection."Am.J.Gastroenterol.. 98. 1500-1503 (2003)
S.Imamura:“蟑螂感染幽门螺杆菌的媒介潜力。”Am.J.Gastroenterol.. 98. 1500-1503 (2003)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
T.Shimomura: "New indication for endoscopic treatment of colorectal carcinoma with submucosal invasion."J.Gastroenterol.Hepatol.. 19. 48-55 (2004)
T.Shimomura:“内窥镜治疗粘膜下侵犯结直肠癌的新适应症。”J.Gastroenterol.Hepatol.. 19. 48-55 (2004)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
New indication for endoscopic treatment of colorectal carcinoma with submucosal invasion
- DOI:10.1111/j.1440-1746.2004.03261.x
- 发表时间:2004-01-01
- 期刊:
- 影响因子:4.1
- 作者:Shimomura, T;Ishiguro, S;Kodama, T
- 通讯作者:Kodama, T
Plasma Coagulation : in vivo tissue damage to the esophagus and stomach and clinical efficacy for early esophageal and gastric cancer.
血浆凝固:对食管和胃的体内组织损伤以及早期食管和胃癌的临床疗效。
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:S.Mitsufuji
- 通讯作者:S.Mitsufuji
Vector potential of cockroaches for Helicobacter pylori infection
- DOI:10.1111/j.1572-0241.2003.07516.x
- 发表时间:2003-07
- 期刊:
- 影响因子:9.8
- 作者:Shigeyoshi Imamura;M. Kita;Y. Yamaoka;Toshiro Yamamoto;A. Ishimaru;H. Konishi;Naoki Wakabayashi;S. Mitsufuji;T. Okanoue;J. Imanishi
- 通讯作者:Shigeyoshi Imamura;M. Kita;Y. Yamaoka;Toshiro Yamamoto;A. Ishimaru;H. Konishi;Naoki Wakabayashi;S. Mitsufuji;T. Okanoue;J. Imanishi
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KONISHI Hideyuki其他文献
KONISHI Hideyuki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KONISHI Hideyuki', 18)}}的其他基金
SIRT1 expression, activity and NAD+ regulation using noncancerous liver tissue specimens from hepatocellular carcinoma patients with non-B non-C hepatitis.
使用患有非乙型非丙型肝炎的肝细胞癌患者的非癌性肝组织标本进行 SIRT1 表达、活性和 NAD 调节。
- 批准号:
25861197 - 财政年份:2013
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Development of novel substrate-recognizable catalysts utilizing reversible formation of covalent bonds
利用共价键的可逆形成开发新型底物可识别催化剂
- 批准号:
23790016 - 财政年份:2011
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Risk analysis for gastric cancer before and after Helicobacter pylori eradication therapy by way of change in RUNX3 expression
通过RUNX3表达变化分析幽门螺杆菌根除治疗前后胃癌风险
- 批准号:
19590730 - 财政年份:2007
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Evaluation of impact of cyclooxygenase-2 inhibitors on cisplatin-induced nephrotoxicity
环氧合酶 2 抑制剂对顺铂肾毒性影响的评价
- 批准号:
19K16437 - 财政年份:2019
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Physiological role of cyclooxygenase 2 in the uterus
环氧合酶 2 在子宫中的生理作用
- 批准号:
19K18630 - 财政年份:2019
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Role of Cyclooxygenase-2 as a Folding Factor of Vascular Endothelial Growth Factor in Normoxia and Hypoxia
环加氧酶-2作为血管内皮生长因子折叠因子在常氧和缺氧中的作用
- 批准号:
544799-2019 - 财政年份:2019
- 资助金额:
$ 1.34万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Master's
Cyclooxygenase-2: an endogenous neuromodulator in seizures and epileptogenesis
Cyclooxygenase-2:癫痫发作和癫痫发生中的内源性神经调节剂
- 批准号:
8812384 - 财政年份:2014
- 资助金额:
$ 1.34万 - 项目类别:
Impact of cyclooxygenase 2-dependent generated prostaglandin E2 and other prostanoids in the development of diet-induced non-alcoholic steatohepatitis (NASH)
环氧合酶 2 依赖性生成的前列腺素 E2 和其他前列腺素类药物对饮食诱发的非酒精性脂肪性肝炎 (NASH) 发展的影响
- 批准号:
245981492 - 财政年份:2013
- 资助金额:
$ 1.34万 - 项目类别:
Research Grants
Antitumor effect of the selective cyclooxygenase-2 inhibitor on bone and soft tissue sarcomas.
选择性环氧合酶2抑制剂对骨和软组织肉瘤的抗肿瘤作用。
- 批准号:
25861331 - 财政年份:2013
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Analysis of the role of cyclooxygenase 2 on spermatogenesis disturbance.
环氧合酶2对精子发生干扰的作用分析。
- 批准号:
24592449 - 财政年份:2012
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Research on new treatment against bone resorption by oral squamous cell carcinoma targeting mammalian target of rapamycin and cyclooxygenase-2.
雷帕霉素和环氧合酶-2哺乳动物靶点抗口腔鳞状细胞癌骨吸收新疗法研究。
- 批准号:
24593007 - 财政年份:2012
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Cyclooxygenase-2 Inhibitors as Radiosensitizers in Cancer Therapy
环加氧酶 2 抑制剂作为癌症治疗中的放射增敏剂
- 批准号:
254427 - 财政年份:2012
- 资助金额:
$ 1.34万 - 项目类别:
Studentship Programs
Regulation of anti-tumor immunity by targeting cyclooxygenase-2 expressing cells
通过靶向 cyclooxygenase-2 表达细胞调节抗肿瘤免疫
- 批准号:
23701076 - 财政年份:2011
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Young Scientists (B)